IRIS
BRUNETTI, ORONZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.561
AS - Asia 1.616
EU - Europa 1.224
SA - Sud America 431
Continente sconosciuto - Info sul continente non disponibili 234
AF - Africa 74
OC - Oceania 3
AN - Antartide 1
Totale 8.144
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.485
SG - Singapore 650
IT - Italia 404
CN - Cina 335
BR - Brasile 328
SE - Svezia 225
HK - Hong Kong 202
RU - Federazione Russa 159
VN - Vietnam 136
FR - Francia 103
DE - Germania 92
GB - Regno Unito 79
IN - India 63
FI - Finlandia 50
AR - Argentina 40
BD - Bangladesh 35
CA - Canada 32
ID - Indonesia 31
TR - Turchia 28
BE - Belgio 25
CO - Colombia 20
MX - Messico 20
ZA - Sudafrica 20
PL - Polonia 17
CI - Costa d'Avorio 15
PK - Pakistan 15
IQ - Iraq 14
EC - Ecuador 13
VE - Venezuela 13
JP - Giappone 12
ES - Italia 11
UA - Ucraina 11
UZ - Uzbekistan 11
MA - Marocco 10
MY - Malesia 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
PH - Filippine 7
CL - Cile 6
ET - Etiopia 6
IL - Israele 6
IR - Iran 6
JO - Giordania 6
KE - Kenya 6
CH - Svizzera 5
JM - Giamaica 5
PY - Paraguay 5
SA - Arabia Saudita 5
AT - Austria 4
EG - Egitto 4
KR - Corea 4
KZ - Kazakistan 4
NL - Olanda 4
NP - Nepal 4
PS - Palestinian Territory 4
AU - Australia 3
BO - Bolivia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
IE - Irlanda 3
KW - Kuwait 3
LT - Lituania 3
NI - Nicaragua 3
TN - Tunisia 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
CR - Costa Rica 2
DK - Danimarca 2
HN - Honduras 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MM - Myanmar 2
MU - Mauritius 2
QA - Qatar 2
RS - Serbia 2
SV - El Salvador 2
UY - Uruguay 2
AQ - Antartide 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
CG - Congo 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
KY - Cayman, isole 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
Totale 7.902
Salva come PNG Salva come JPEG
Città #
Fairfield 519
Ashburn 517
Chandler 443
Singapore 372
Woodbridge 283
Seattle 251
Cambridge 220
Houston 213
Milan 204
Hong Kong 198
San Jose 187
Nyköping 182
Wilmington 171
Beijing 111
Ann Arbor 109
Dearborn 103
Council Bluffs 94
Dallas 74
New York 74
Lawrence 57
Los Angeles 55
Roxbury 55
Rome 53
Lauterbourg 51
Ho Chi Minh City 42
Munich 41
Brooklyn 40
Des Moines 36
Santa Clara 34
Boardman 32
São Paulo 32
The Dalles 30
Nanjing 29
Helsinki 26
San Diego 25
Brussels 24
Columbus 24
Dong Ket 24
Moscow 24
Hanoi 22
Jakarta 22
Bari 20
Turku 19
Chicago 17
Paris 17
Frankfurt am Main 16
Abidjan 15
Inglewood 15
Montreal 15
Chennai 14
Hefei 14
Turin 14
Figino 13
Phoenix 13
Pune 13
Warsaw 13
Buffalo 12
Da Nang 12
London 12
Orem 12
Tokyo 12
Denver 11
Marseille 11
San Francisco 11
Shanghai 10
Belo Horizonte 9
Johannesburg 9
Stockholm 9
Tashkent 9
Guangzhou 8
Jinan 8
Lahore 8
Manchester 8
Naples 8
Poplar 8
Rio de Janeiro 8
San Mateo 8
Atlanta 7
Düsseldorf 7
Mumbai 7
Nuremberg 7
Washington 7
Amman 6
Augusta 6
Brno 6
Campinas 6
Curitiba 6
Dhaka 6
Edinburgh 6
Jacksonville 6
Mexico City 6
Addis Ababa 5
Baghdad 5
Blumenau 5
Istanbul 5
Kilburn 5
Kingston 5
Kunming 5
Miami 5
Monmouth Junction 5
Totale 5.668
Salva come PNG Salva come JPEG
Nome #
Mast cells and angiogenesis in pancreatic ductal adenocarcinoma 259
Angiogenesis in adenosquamous cancer of pancreas 229
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer 199
Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma 194
Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue 193
Fisiologia V Ed. 189
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells 183
Targeting angiogenesis in biliary tract cancers: An open option 178
Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review 177
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 175
Inflammatory cells infiltrate and angiogenesis in locally advanced and metastatic cholangiocarcinoma 175
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol 167
Systematic review of irreversible electroporation role in management of locally advanced pancreatic cancer 166
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma 165
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review 163
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 163
Bone metastases in biliary cancers: A multicenter retrospective survey 163
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib 161
Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance 157
Strategies to improve cancer immune checkpoint inhibitors efficacy, other than abscopal effect: A systematic review 156
Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma 153
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: A retrospective study 150
Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis 141
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine 141
Multimodal treatment of resectable pancreatic ductal adenocarcinoma 140
Micro-RNA in pancreatic adenocarcinoma: Predictive/prognostic biomarkers or therapeutic targets? 140
Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma 140
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 139
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib 138
Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review 138
Molecular characterization of a long-term survivor double metastatic non-small cell lung cancer and pancreatic ductal adenocarcinoma treated with gefitinib in combination with gemcitabine plus nab-paclitaxel and mFOLFOX6 as first and second line therapy 132
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials 130
Immunotherapy for colorectal cancer: where are we heading? 128
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option? 125
COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients? 123
Management of patients with end-stage renal disease undergoing chemotherapy: Recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN) 123
The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy 121
The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following? 119
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 117
Bone metastases in hepatocellular carcinoma: an emerging issue 117
Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection 111
Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets 110
Basics and frontiers on pancreatic cancer for radiation oncology: Target delineation, SBRT, SIB technique, MRgRT, particle therapy, immunotherapy and clinical guidelines 110
Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: A potential treatment for breast cancer 109
Clinical practice guidelines for diagnosis, treatment and follow-up of exocrine pancreatic ductal adenocarcinoma: Evidence evaluation and recommendations by the italian association of medical oncology (AIOM) 106
A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery 105
Immune system and bone microenvironment: rationale for targeted cancer therapies 99
Paraneoplastic focal segmental glomerulosclerosis in sarcomatoid renal cell cancer. 98
Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma: Could Surgery Represent a Therapeutic Option? 98
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations 98
NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer 91
Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies 84
The latest findings of PD-1/PD-L1 inhibitor application in gynecologic cancers 84
null 81
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis 68
null 67
Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel? 62
Is it Time for a Therapeutic Algorithm in Resected Pancreatic Ductal Adenocarcinoma? 62
null 61
On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents 53
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 51
The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead 49
Identification of Common and Distinct Pathways in Inflammatory Bowel Disease and Colorectal Cancer: A Hypothesis Based on Weighted Gene Co-Expression Network Analysis 20
Totale 8.144
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.551
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.551
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022448 0 0 13 15 20 45 17 30 37 46 68 157
2022/2023929 104 155 85 75 85 95 15 113 140 5 40 17
2023/2024324 19 59 15 28 33 95 7 9 3 7 3 46
2024/20251.210 53 11 85 51 47 111 103 107 44 79 197 322
2025/20262.612 405 115 168 281 326 124 258 80 272 215 63 305
2026/2027245 60 97 88 0 0 0 0 0 0 0 0 0
Totale 8.144